USD 15.06
(-2.59%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 4.38 Million | 9.31 Million | 15.78 Million | 5.19 Million | 5.59 Million | 8.57 Million |
Net Income | 8.7 Million | 8.95 Million | 7.58 Million | 4.98 Million | 5.6 Million | 5.3 Million |
Depreciation & Amortization | 1.96 Million | 2.6 Million | 2.05 Million | 2.02 Million | 1.66 Million | 930 Thousand |
Deferred income taxes | -356 Thousand | -10 Thousand | 114 Thousand | -838 Thousand | -17 Thousand | -132 Thousand |
Stock-based compensation | - | - | 106 Thousand | 106 Thousand | 106 Thousand | - |
Change in working capital | -2.73 Million | -1.24 Million | 336 Thousand | -916 Thousand | -50 Thousand | 164 Thousand |
Other non-cash items | 745 Thousand | -997 Thousand | 5.58 Million | -162 Thousand | -1.71 Million | 3.91 Million |
Investing Cash Flow | -18.23 Million | -88.12 Million | -64.46 Million | -62.05 Million | -52.52 Million | -38.76 Million |
Investments in PPE | -3.37 Million | -1.19 Million | -2.9 Million | -1.75 Million | -4.39 Million | -2.3 Million |
Acquisitions | 8.74 Million | -818 Thousand | -10.4 Million | -31.22 Million | -44.56 Million | -40.56 Million |
Investment purchases | -34.85 Million | -77.48 Million | -83.96 Million | -51.15 Million | -16.99 Million | -998 Thousand |
Sales/Maturities of investments | 12.66 Million | 19.39 Million | 8.36 Million | 23.15 Million | 12.9 Million | 4.2 Million |
Other Investing Activities | -1.41 Million | -28.03 Million | 24.44 Million | -1.07 Million | 526 Thousand | 889 Thousand |
Financing Cash Flow | 26.91 Million | -42.57 Million | 130.94 Million | 118.62 Million | 35.71 Million | 43.5 Million |
Debt repayment | -944 Thousand | -889 Thousand | -414 Thousand | -5.41 Million | -156 Thousand | - |
Dividends payments | -1.46 Million | -1.36 Million | -1.27 Million | -1.21 Million | -1.22 Million | -1.05 Million |
Common Stock Repurchased | -997 Thousand | -1.4 Million | -427 Thousand | -275 Thousand | -315 Thousand | - |
Common Stock Issuance | 30.89 Million | - | 133.07 Million | 10.02 Million | - | - |
Other Financing Activities | -577 Thousand | -38.91 Million | -16 Thousand | 115.5 Million | 37.41 Million | 44.55 Million |
Accounts receivables | -99 Thousand | -672 Thousand | 286 Thousand | -484 Thousand | -124 Thousand | -29 Thousand |
Accounts payables | 391 Thousand | 43 Thousand | -39 Thousand | -88 Thousand | 46 Thousand | 16 Thousand |
Inventory | - | - | 519 Thousand | 92 Thousand | 707 Thousand | 518 Thousand |
Other working capital | -3.02 Million | -620 Thousand | -430 Thousand | -436 Thousand | -679 Thousand | -341 Thousand |
Cash at beginning of period | 61.76 Million | 183.15 Million | 100.88 Million | 39.11 Million | 50.32 Million | 37.01 Million |
Cash at end of period | 74.83 Million | 61.76 Million | 183.15 Million | 100.88 Million | 39.11 Million | 50.32 Million |
Capital Expenditure | -3.37 Million | -1.19 Million | -2.9 Million | -1.75 Million | -4.39 Million | -2.3 Million |
Effect of forex changes on cash | -14.86 Million | - | - | - | - | - |
Net cash flow / Change in cash | 13.07 Million | -121.39 Million | 82.26 Million | 61.77 Million | -11.21 Million | 13.3 Million |
Free Cash Flow | 1.01 Million | 8.12 Million | 12.87 Million | 3.44 Million | 1.19 Million | 6.27 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 2.14 Million | 2.18 Million | 2.1 Million | 8.7 Million | 2.07 Million | 2.53 Million |
Depreciation & Amortization | 486 Thousand | 484 Thousand | 468 Thousand | 1.96 Million | 403 Thousand | 465 Thousand |
Deferred income taxes | - | - | -356 Thousand | -356 Thousand | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 613 Thousand | 86 Thousand | -2.73 Million | -2.73 Million | -866 Thousand | -26 Thousand |
Other non-cash items | 608 Thousand | -564 Thousand | 2.03 Million | 745 Thousand | 1.75 Million | -5.2 Million |
Investing Cash Flow | -7.03 Million | -2.33 Million | -22.92 Million | -18.23 Million | 10.11 Million | 9.27 Million |
Investments in PPE | -113 Thousand | -1.07 Million | -96 Thousand | -3.37 Million | -1.16 Million | -121 Thousand |
Acquisitions | - | - | -19.05 Million | 8.74 Million | 10.99 Million | 8.05 Million |
Investment purchases | -3.84 Million | -8.16 Million | -26.68 Million | -34.85 Million | -3.96 Million | -1.42 Million |
Sales/Maturities of investments | 11.82 Million | 8.05 Million | 3.35 Million | 12.66 Million | 3.93 Million | 2.69 Million |
Other Investing Activities | -29 Thousand | -600 Thousand | 505 Thousand | -1.41 Million | 316 Thousand | 70 Thousand |
Financing Cash Flow | -9.29 Million | 14.34 Million | -2.34 Million | 26.91 Million | 12.51 Million | 1.87 Million |
Debt repayment | -241 Thousand | -242 Thousand | -243 Thousand | -944 Thousand | -235 Thousand | -232 Thousand |
Dividends payments | -457 Thousand | -453 Thousand | -361 Thousand | -1.46 Million | -366 Thousand | -364 Thousand |
Common Stock Repurchased | - | - | - | -997 Thousand | - | -184 Thousand |
Common Stock Issuance | - | - | - | 30.89 Million | - | - |
Other Financing Activities | -8.59 Million | 14.88 Million | -1.74 Million | -577 Thousand | 13.11 Million | 2.65 Million |
Accounts receivables | 16 Thousand | -101 Thousand | -128 Thousand | -99 Thousand | -182 Thousand | 49 Thousand |
Accounts payables | 31 Thousand | 42 Thousand | 99 Thousand | 391 Thousand | 112 Thousand | 51 Thousand |
Inventory | - | - | - | - | - | - |
Other working capital | 566 Thousand | 187 Thousand | -2.7 Million | -3.02 Million | -796 Thousand | -126 Thousand |
Cash at beginning of period | 88.07 Million | 74.83 Million | 99.52 Million | 61.76 Million | 73.52 Million | 64.6 Million |
Cash at end of period | 74.62 Million | 88.07 Million | 74.83 Million | 74.83 Million | 99.52 Million | 73.52 Million |
Capital Expenditure | -113 Thousand | -1.07 Million | -96 Thousand | -3.37 Million | -1.16 Million | -121 Thousand |
Effect of forex changes on cash | - | - | - | -14.86 Million | - | - |
Net cash flow / Change in cash | -13.44 Million | 13.23 Million | -24.69 Million | 13.07 Million | 26 Million | 8.92 Million |
Free Cash Flow | 2.77 Million | 146 Thousand | 487 Thousand | 1.01 Million | 2.2 Million | -2.34 Million |
XOSWW
MOREPENLAB
SKUFF
GTMEY
TM5
VEERHEALTH